Woman Alleges Merck Failed to Disclose Risks of Fosamax, Rottenstein Law Group Reports NEW YORK, March 13, 2013 (GLOBE NEWSWIRE) -- The first trial to feature claims that Merck hid the alleged bone-weakening, femur-fracturing side effects of Fosamax began this week.* Christina Su, 67,...